Santarus began Phase III clinical testing of rifamycin SV.    From Wordnik.com.  [PharmaLive: Santarus Adds Two Novel Biologic Drug Candidates to Pipeline] Reference

At best, rifamycin SV MMX is still years from the market.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

Couple of questions on rifamycin, how do you believe the product is differentiated from Xifaxan?.    From Wordnik.com.  [SeekingAlpha.com: Home Page] Reference

The company also possesses a phase III ready candidate in rifamycin SV MMX for traveler's diarrhea.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

Do you think you'll run any additional studies in parallel with the phase III program for rifamycin?.    From Wordnik.com.  [SeekingAlpha.com: Home Page] Reference

There are number of development activity that Cosmo is currently undertaking with rifamycin SV MMX in.    From Wordnik.com.  [SeekingAlpha.com: Home Page] Reference

III clinical testing of rifamycin SV MMX in patients with travelers 'diarrhea in the second quarter of 2010.    From Wordnik.com.  [BioSpace.com Featured News and Stories] Reference

Both budesonide MMX and rifamycin SV MMX address serious lower GI conditions treated by gastroenterologists.    From Wordnik.com.  [SeekingAlpha.com: Home Page] Reference

Santarus is also developing two late-stage lower GI compounds, budesonide MMX® and rifamycin SV MMX® for the U.S. market.    From Wordnik.com.  [Health News from Medical News Today] Reference

These forward-looking statements include statements regarding the timing of the Phase III clinical studies for rifamycin SV MMX.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

Santarus is also developing two late-stage GI product candidates, budesonide MMX (®) and rifamycin SV MMX (®), for the US market.    From Wordnik.com.  [BioSpace.com Featured News and Stories] Reference

Santarus is also developing two late-stage lower GI product candidates, budesonide MMX® and rifamycin SV MMX®, for the U.S. market.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

Santarus expects to begin Phase III clinical testing of rifamycin SV MMX in patients with travelers 'diarrhea in the first half of 2010.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

Santarus expects to begin Phase III clinical testing of rifamycin SV MMX in patients with travelers 'diarrhea in the second quarter of 2010.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

Meanwhile, pipeline candidates budesonide MMX and rifamycin SV MMX, if successfully developed, are not likely to hit the market before 2012.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

A newer entrant to 5-ASA category, Lialda is formulated with MMX technology, the same technology used with budesonide MMX and rifamycin SV MMX.    From Wordnik.com.  [SeekingAlpha.com: Home Page] Reference

You talked about rifamycin and the additional indications. when might you and Dr. Falk make a decision on going forward with one of those plans?.    From Wordnik.com.  [SeekingAlpha.com: Home Page] Reference

XIFAXAN is contraindicated in patients with a hypersensitivity to rifaximin, any of the rifamycin antimicrobial agents, or any of the components in XIFAXAN.    From Wordnik.com.  [XIFAXAN 550 mg (Rifaximin) Demonstrates Acute and Sustained Relief of Non-Constipation Irritable Bowel Syndrome Symptoms: Data Presented at the 2010 American College of Gastroenterology (ACG) Annual Meeting - Yahoo! Finance] Reference

In addition to the targeted drug delivery, the company believes the negligible absorption of rifamycin SV MMX will offer an opportunity for limited side effects.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

Turning the rifamycin SV MMX, we currently plan we currently to file an investigational new drug application with the FDA for rifamycin SV MMX in the second half of 2009.    From Wordnik.com.  [SeekingAlpha.com: Home Page] Reference

XDR-TB was defined as strains resistant to isoniazid, a rifamycin, a fluoroquinolone, and at least one of amikacin, kanamycin, or capreomycin in drug susceptibility tests.    From Wordnik.com.  [Medlogs - Recent stories] Reference

In the long term, we like the position of the company, especially if Santarus can hold on to Zegerid until either budesonide or rifamycin − or both − gets on the market.    From Wordnik.com.  [SeekingAlpha.com: Home Page] Reference

Longer term we believe that budesonide MMX and rifamycin SV MMX represents significant upside potential in the years to come in the GI specialty markets we currently address.    From Wordnik.com.  [SeekingAlpha.com: Home Page] Reference

When formulated with the MMX technology, rifamycin SV MMX is delivered to the colon, which we believe will minimize unwanted side effects on the normal flora in the small intestine.    From Wordnik.com.  [SeekingAlpha.com: Home Page] Reference

We are currently investigating the potential for rifamycin SV MMX in these diseases through a research of clinical literature and discussion with medical experts in these disease states.    From Wordnik.com.  [SeekingAlpha.com: Home Page] Reference

Based on a pre-IND meeting in early 2009, the FDA determined that rifamycin SV MMX is a new molecular entity (NME) in the U.S. and requested a full preclinical assessment prior to submitting an IND.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

The application of MMX technology to rifamycin SV allows the antibiotic to be delivered directly to the colon, optimizing drug levels in the colon where the pathogens of travelers 'diarrhea are predominant.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

TB was defined as resistance to isoniazid, a rifamycin, a fluoroquinolone, and at least 1 of amikacin, kanamycin, or capreomycin based on drug susceptibility test results from initial and follow-up specimens.    From Wordnik.com.  [JAMA current issue] Reference

XDR-TB was defined as resistance to isoniazid, a rifamycin, a fluoroquinolone, and at least one of amikacin, kanamycin, or capreomycin based on drug susceptibility test results from initial and follow-up specimens.    From Wordnik.com.  [Kansas City infoZine Headlines] Reference

® for induction of remission of active ulcerative colitis, rifamycin SV MMX.    From Wordnik.com.  [Santarus to Hold Third Quarter 2010 Financial Results Conference Call on November 8 - Yahoo! Finance] Reference

™ budesonide MMX® for induction of remission of active ulcerative colitis, rifamycin SV MMX.    From Wordnik.com.  [Santarus and Depomed Announce Availability of GLUMETZA 500 mg Tablets - Yahoo! Finance] Reference

® and rifamycin SV MMX® - in Phase III clinical programs and a promising earlier stage anti-VLA-1 antibody, all of which offer significant commercial potential.    From Wordnik.com.  [PharmaLive: Santarus Adds Two Novel Biologic Drug Candidates to Pipeline] Reference

Rifampin (rifampicin, rifamycin).    From Wordnik.com.  [Chapter 31] Reference

The Dr. Falk Phase III study will assess the efficacy (non-inferiority) and safety of rifamycin SV MMX 400 mg (2.    From Wordnik.com.  [The Earth Times Online Newspaper] Reference

® and rifamycin SV MMX® for the U.S. market.    From Wordnik.com.  [Digital50.com Digital 50 Daily Industry News RSS Feed] Reference

® and rifamycin SV MMX®, for the U.S. market.    From Wordnik.com. Reference